These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2656909)

  • 21. Recent rubella virus infection indicated by a low avidity of specific IgG.
    Hedman K; Seppälä I
    J Clin Immunol; 1988 May; 8(3):214-21. PubMed ID: 3292566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An ELISA for the estimation of high-avidity and total specific IgG and IgM antibodies to rubella virus.
    Lehtonen OP; Meurman OH
    J Virol Methods; 1982 Sep; 5(1):1-10. PubMed ID: 7142359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of various serological methods and diagnostic kits for the detection of acute, recent, and previous rubella infection, vaccination, and congenital infections.
    Enders G; Knotek F; Pacher U
    J Med Virol; 1985 Jul; 16(3):219-32. PubMed ID: 2993493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rubella vaccination: persistence of antibodies for up to 16 years.
    O'Shea S; Best JM; Banatvala JE; Marshall WC; Dudgeon JA
    Br Med J (Clin Res Ed); 1982 Jul; 285(6337):253-5. PubMed ID: 6807437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody response to wild rubella virus structural proteins following immunization with RA 27/3 live attenuated vaccine.
    Cusi MG; Rossolini GM; Cellesi C; Valensin PE
    Arch Virol; 1988; 101(1-2):25-33. PubMed ID: 3046563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reliability of low-avidity IgG and of IgA in the diagnosis of primary infection by rubella virus with adaptation of a commercial test.
    Gutiérrez J; Rodríguez MJ; De Ory F; Piédrola G; Maroto MC
    J Clin Lab Anal; 1999; 13(1):1-4. PubMed ID: 10025730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemagglutination inhibition, single radial hemolysis, and ELISA tests for the detection of IgG and IgM to rubella virus.
    Champsaur H; Dussaix E; Tournier P
    J Med Virol; 1980; 5(4):273-86. PubMed ID: 7014780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiation of primary cytomegalovirus infection from reactivation using the urea denaturation test for measuring antibody avidity.
    Blackburn NK; Besselaar TG; Schoub BD; O'Connell KF
    J Med Virol; 1991 Jan; 33(1):6-9. PubMed ID: 1849983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement in establishing the period of rubella virus primary infection using a mild protein denaturant.
    Condorelli F; Stivala A; Gallo R; Musumeci E; Scatà MC; Strano L; Pennisi M; Russo G; Castro A; Scalia G
    J Virol Methods; 1997 Jun; 66(1):109-12. PubMed ID: 9220396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years.
    Johnson CE; Kumar ML; Whitwell JK; Staehle BO; Rome LP; Dinakar C; Hurni W; Nalin DR
    Pediatr Infect Dis J; 1996 Aug; 15(8):687-92. PubMed ID: 8858673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-serum diagnosis of recent rubella infection with the use of hemagglutination inhibition test and enzyme-linked immunosorbent assays.
    Katow S; Sugiura A; Janejai N
    Microbiol Immunol; 1989; 33(2):141-5. PubMed ID: 2716546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Duration of immunity after rubella vaccination: a long-term study in Switzerland.
    Just M; Just V; Berger R; Burkhardt F; Schilt U
    Rev Infect Dis; 1985; 7 Suppl 1():S91-4. PubMed ID: 4001742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of automated immunoassays for immune status screening and serodiagnosis of rubella virus infection.
    Abbott GG; Safford JW; MacDonald RG; Craine MC; Applegren RR
    J Virol Methods; 1990 Feb; 27(2):227-39. PubMed ID: 2318930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Avidity of rubella IgG antibody in rubella virus infection].
    Hoshiba T; Nishimoto H; Asamoto A; Yabuki Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Dec; 45(12):1389-93. PubMed ID: 8270822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The avidity of specific IgM detected in primary rubella and reinfection.
    Thomas HI; Morgan-Capner P
    Epidemiol Infect; 1990 Jun; 104(3):489-97. PubMed ID: 2347387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serological response to rubella revaccination in adolescent females.
    Fitzpatrick SB; Anthony R; Heald F
    J Adolesc Health Care; 1983 Sep; 4(3):168-70. PubMed ID: 6629973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Humoral immune response after primary rubella virus infection and after vaccination.
    Vauloup-Fellous C; Grangeot-Keros L
    Clin Vaccine Immunol; 2007 May; 14(5):644-7. PubMed ID: 17344342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of rubella ELISA background using heat denatured sample buffer.
    Mauracher CA; Mitchell LA; Tingle AJ
    J Immunol Methods; 1991 Dec; 145(1-2):251-4. PubMed ID: 1765659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The development of immune-enzyme test-systems to diagnose rubella].
    Mardanly SG; Amelina EA; Gafarov RR
    Klin Lab Diagn; 2012 May; (5):46-8. PubMed ID: 22834161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of immunoglobulin G avidity assays for differentiation of primary from previous infections with West Nile virus.
    Levett PN; Sonnenberg K; Sidaway F; Shead S; Niedrig M; Steinhagen K; Horsman GB; Drebot MA
    J Clin Microbiol; 2005 Dec; 43(12):5873-5. PubMed ID: 16333069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.